Educational research only—not investment advice or a recommendation. Scores and estimates may use delayed, incomplete, restated, or corrected market and filing data. Independently verify information before making an investment decision.
Price from Oct 29, 2026Financials updated Oct 1, 2026
Explore stock sections · swipe left or right
LFVN · Price history
Price at last available close
$5.89
−$0.43 (-6.80%) 1M
2026-10-28
Tap or drag sideways to inspect a price. Use two fingers to compare automatically. Release to scroll. Use Shift + arrow keys to compare with a keyboard.
Primary reporting period: 2026-06-30 · Research updated Oct 12, 2026. A research update is not a new financial filing.
Who they are
LifeVantage Corporation (LFVN) specializes in the development, manufacture, and distribution of a diverse portfolio of health, wellness, and personal care products. Its offerings encompass nutrigenomic activators (designed to influence genetic expression), a broad array of dietary supplements, cognitive enhancers (nootropics), gut health support (pre- and pro-biotics), weight management solutions, and various personal care items spanning skin care, hair care, bath and body, and targeted relief. The company's product lineup features well-known brands such as Protandim, a series of scientifically validated dietary supplements.
How they make money
LifeVantage Corporation operates as a direct-selling company that markets and distributes health and wellness products through a global network of independent consultants. The company generates revenue primarily through the sale of these products to its independent consultant network and directly to customers, while incurring costs related to product manufacturing, distribution, and commissions paid to consultants based on their sales performance.
Products & services
The company offers a portfolio of nutrigenomic-based dietary supplements, skin and hair care products, weight management items, and nootropic energy drinks, including brands such as Protandim, TrueScience, PhysIQ, Petandim, and AXIO.
Brands & revenue mix
Protandim
Flagship dietary supplement line based on nutrigenomic research.
Separate brand revenue is not available in this research.Source
TrueScience
Skin and hair care product line.
Separate brand revenue is not available in this research.Source
AXIO
Nootropic energy drink line.
Separate brand revenue is not available in this research.Source
PhysIQ
Weight management product line.
Separate brand revenue is not available in this research.Source
Petandim
Dietary supplement line for pets.
Separate brand revenue is not available in this research.Source
Revenue share is not unit sales or a best-seller ranking. Parent brands and included sub-brands can overlap; do not add overlapping rows.
Product / operating segments
No reconciled product or operating-segment revenue breakdown is available for the current research period. Company-wide revenue remains separate from segment disclosure.
Geographic revenue
No reconciled geographic revenue breakdown was confirmed for the current research period.
The company does not rely on any single customer for a significant portion of its revenue, as its business model is based on a large network of independent consultants and individual retail customers.
Suppliers, materials & equipment
Contract Manufacturers — The company utilizes various third-party contract manufacturers to produce its dietary supplements and personal care products.Source
Competitors
Direct Selling Companies — The company competes with various other direct selling organizations that offer health, wellness, and personal care products.Source
Overall investment score · Quality, value, risk and opportunity
39
Poor
PoorElite
View category scores →
Company Quality
How good is the actual business—regardless of today’s stock price?
60
Fair
Financial Strength
75
Business Quality / Moat
26
Management
100
Growth Quality
18
Risk / Durability
78
Weak Company · Expensive Stock
Uses financial strength, moat, management, growth quality and durability. It excludes share price, P/E, market cap, intrinsic value and margin of safety.
Opportunity
Opportunity Score · How does the current price compare with estimated value?
20
Avoid
Based on current valuation, company quality, recent trends, and available market signals.
View score details →
Model Outlook
12-month model · What does the model think happens next?
26/100
Building Historical Record
Model Score 26/100 — estimates relative performance potential, distinct from the overall Wall Street Score and the separate Company Quality score.
Probability unavailable — the model has not produced a calibrated probability yet.
Click for full breakdown →
WSS View
The quick read
The overall Wall Street Score is low across its combined quality, valuation and risk inputs. This can reflect an expensive share price, business weaknesses, or both; check Company Quality and the category breakdown before drawing a conclusion.
At today’s price, the WSS valuation framework currently reads as less attractive based on the available valuation and market data.
The model outlook is currently cautious.
What we like
•Balance-sheet / debt profile scores strongly
•Recent buyback activity is present
What to watch
•Valuation is a weaker part of the current profile
•Revenue fundamentals are weak
•Asset quality is a weaker factor
Company-specific research
Questions worth answering for LFVN
Research inputs 100% complete
These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.
•Can LFVN maintain its current revenue growth rate and improve the amount of that revenue that turns into earnings and cash?
•Is LFVN's positive free cash flow repeatable, or is the current level being helped by temporary working-capital or spending changes?
•How is LFVN likely to use its cash advantage: reinvestment, acquisitions, debt reduction, dividends or buybacks?
•What future growth or profitability would be needed to justify LFVN's current valuation?
Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.
A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.
Volatility = How violently is it moving?
A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.
Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.
Notices for LFVN
Detected from reported data — verify before acting.
Dividend history reported
Dividend payments are recorded. Review the dates and regular/special classification below; past payments do not guarantee future dividends.
Historical repurchase activity
Reported cash flows or share-count measures indicate past repurchase activity. This does not verify an active buyback authorization or future purchases.
Community Sentiment
0 active · 0 total calls
0% Bullish (0) 0% Bearish (0)
No personal call yet on LFVN.
Potential upside factors
+Growth opportunities may come from revenue expansion, margin improvement, new products, market-share gains, and stronger cash flow.
+Science-based nutrigenomic product portfolio.
+Established network marketing distribution model.
+Positive free cash flow may provide capacity to invest in growth.
Potential downside factors
−Key risks may include competition, margin pressure, debt levels, valuation risk, and changes in demand within the Packaged Foods industry.
−Regulatory compliance risks associated with direct selling programs.
−Dependence on independent consultants for sales growth.
These research factors come from saved company research and financial data, not community votes. They are starting points to verify against filings, not buy or sell recommendations.
Create a free account to make a call.
Scores
Click any score for full breakdown
Wall Street Score
Weak39/ 100
Weak (0–50)Fair (51–71)Strong (72+)
Debt
Strong
83
Debt Cost—
Debt Reduction YoY15.5%
Debt / Equity0.29x
Tap for breakdown →
Revenue
Poor
28
Revenue YoY0.0%
Revenue CAGR-4.5%
Net Margin2.8%
Tap for breakdown →
Asset
Poor
37
Asset Growth YoY-13.7%
Liquidation/Share$2.64
Net Assets/MCap0.66x
Tap for breakdown →
Capital
Fair
55
Earnings Yield6.4%
Buyback Yield4.3%
Debt Cost—
Tap for breakdown →
Management
Elite
100
ROIC17.9%
ROE15.1%
ROA8.2%
Tap for breakdown →
Moat
Poor
26
EPS Growth-8.8%
FCF/Share Growth-3.4%
Rev/Share Growth-5.1%
Tap for breakdown →
Valuation
Poor
22
Intrinsic Value$3.40
Value Reference$2.04
MOS-73.5%
Tap for breakdown →
Buffett
Fair
53
Revenue28
Moat26
Valuation22
Tap for breakdown →
MOS
Poor
0
MOS %-73.5%
Value Reference$2.04
Deep Discount Reference$1.36
Tap for breakdown →
Financial
Poor
27
Interest Coverage—
ROIC17.9%
FCF Yield8.4%
Tap for breakdown →
Master
Poor
34
Financial27
Valuation22
Debt83
Tap for breakdown →
Resilience
Weak
48
Survival Years0.1 yrs
Current Ratio1.89x
FCF Margin3.7%
Tap for breakdown →
Was this stock page easy to understand?
One click helps us improve the research experience. This is not tied to an investment decision.
YesNot yetDismiss
Score Changes
2 historical score records available
Previous Score
64
Jul 24, 2026
Change
-24.4
points
Current Score
39
Oct 1, 2026
Category Changes
Revenue-3.7
Debt-14.2
Assets-18.3
Capital-39.0
Management0
Moat-19.6
Valuation-62.9
Buffett-16.2
LFVN decreased 24.4 points because Debt declined by 14.2 points, Revenue declined by 3.7 points, Asset declined by 18.3 points.
Negative Contributors
− Debt declined by 14.2 points
− Revenue declined by 3.7 points
− Asset declined by 18.3 points
− Capital declined by 39 points
− Moat declined by 19.6 points
− Valuation declined by 62.9 points
− Buffett declined by 16.2 points
Projected Score
Projected Score
36
Projected Change
-3.6 points
Preliminary comparable-period financial changes suggest decline of approximately 3.6 points. This is a projected estimate, not the official WallStreetScore.
Monetary values in USD. Share counts in raw units.
Income StatementBalance SheetCash Flow
AnnualQuarterlyTTM + Annual
All rows
Free includes 3 annual periods plus available TTM; Premium includes up to 10 annual periods. History depends on available company filings. Swipe the table horizontally to see older periods. A dash means unavailable, not zero.
Line Item
TTM
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
$182.6M
$182.6M
$228.5M
$200.2M
····
····
····
····
····
····
····
Cost of Revenue
$41.0M
$41.0M
$44.9M
$41.4M
····
····
····
····
····
····
····
Gross Profit
$141.6M
$141.6M
$183.7M
$158.7M
····
····
····
····
····
····
····
Research & Development
$0.00
$0.00
$0.00
$0.00
····
····
····
····
····
····
····
SG&A Expenses
$135.5M
$135.5M
$69.2M
$68.5M
····
····
····
····
····
····
····
Operating Expenses
$135.5M
$135.5M
$171.5M
$154.4M
····
····
····
····
····
····
····
EBITDA
$8.8M
$8.8M
$15.4M
$7.9M
····
····
····
····
····
····
····
Operating Income
$6.1M
$6.1M
$12.2M
$4.3M
····
····
····
····
····
····
····
Interest Expense
$0.00
$0.00
$0.00
$0.00
····
····
····
····
····
····
····
Income Before Tax
$6.1M
$6.1M
$12.2M
$4.3M
····
····
····
····
····
····
····
Income Tax Expense
$994K
$994K
$2.4M
$1.4M
····
····
····
····
····
····
····
Net Income
$5.1M
$5.1M
$9.8M
$2.9M
····
····
····
····
····
····
····
Basic EPS
$0.40
$0.40
$0.80
$0.24
····
····
····
····
····
····
····
Basic Shares
12.53M
12.53M
12.25M
12.46M
····
····
····
····
····
····
····
Diluted Shares
12.70M
12.70M
12.99M
12.99M
····
····
····
····
····
····
····
Upgrade to Premium for up to 10 annual periods, where available.
Debt and cash show percentage changes versus the comparison period; margin shows the change in percentage points (pp). These are company-wide changes, not per-share amounts.
Financial Changes Since Prior Period
What Improved
Debt reduced
What Weakened
Margins contracted
Cash position declined
Potential Score Impact
Positive indicators included debt levels. Pressure indicators included revenue growth, EPS growth, cash levels, net income margin. These factors may support or pressure the Revenue, Management, Financial, and Debt categories; this summary does not claim that the stored scores changed.
Stored Earnings Analysis
Revenue declined 23.1%. EPS declined 34.5%. Cash declined 30.9%. Total debt declined 22.7%. Net income margin declined by 0.5 percentage points.
Earnings-Call Transcript
Earnings-call transcript analysis is not currently available.
These results may influence future scores when the next evaluation is completed.
Upgrade to Premium to unlock all earnings history.View plans
Government disclosed trading activity is available on the Smart Money directory. Filings may be delayed and may not represent complete current holdings.
Dividend HistoryShare
Dividend History
Log in to view dividend history.
Log In
Predictions & Historical PerformanceShare
Conservative Projected Values
3 Years
$———.——
Premium
5 Years
$———.——
Premium
10 Years
$———.——
Premium
Conservative Projection Rate
——%
Premium
Conservative Projected Values — price projections derived from actual 10-year adjusted historical returns, conservatively adjusted and capped at 8% annually. These are distinct from the Outperformance Model Score and WallStreetScore.
Conservative Projected Values
Premium unlocks the 3-year, 5-year, and 10-year conservative projected values with full calculation breakdowns based on actual historical returns.
Premium includes stored forecasts and any available evaluated results. Completed results, win rates and calibrated probabilities are shown only when supported records exist; access does not create historical outcomes.